Status:
NOT_YET_RECRUITING
GLP1-RA and Periodontitis
Lead Sponsor:
Medical University of Graz
Conditions:
Periodontitis
Diabetes (DM)
Eligibility:
All Genders
18+ years
Brief Summary
Periodontitis is among the most common chronic diseases worldwide and, along with caries, represents the leading cause of tooth loss. More recent theories regarding the etiology of periodontitis also ...
Eligibility Criteria
Inclusion
- Written informed consent for participation and data protection
- Diagnosis of type 2 diabetes
- Diagnosis of chronic periodontitis (Caton, Armitage et al. 2018), presence of a PSI ≥ 3 in at least one sextant (Ainamo, Barmes et al. 1982)
Exclusion
- Use of systemic antibiotics within the past 6 months
- Systematic periodontal treatment within the past 24 months
- Consumption of ≥ 5 cigarettes/day
- Unstable cardiovascular disease
- Chronic systemic diseases (e.g., rheumatoid arthritis, Crohn's disease, etc.)
- Pregnancy
- Use of the following medications: Immunosuppressants, Anticonvulsants, Calcium channel blockers
- Drug or medication abuse
Key Trial Info
Start Date :
October 24 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07182123
Start Date
October 24 2025
End Date
June 1 2026
Last Update
September 24 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.